EuPRAXIA Doctoral Network

EuPRAXIA博士网络

• 批准号: EP/X027112/1
• 负责人: Carsten Welsch
• 金额: $ 67.6万
• 依托单位: University of Liverpool
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FX027112%2F1
• 关键词: EuPRAXIA; Doctoral; Network

EuPRAXIA is the first European project that develops a dedicated particle accelerator research infrastructure based on novel plasma acceleration concepts and laser technology. It focuses on the development of electron accelerators and underlying technologies, their user communities, and the exploitation of existing accelerator infrastructures in Europe. It was accepted onto the ESFRI roadmap for strategically important research infrastructures in June 2021 as a European priority. To fully exploit the potential of this breakthrough facility, advances are urgently required in plasma and laser R&D, studies into facility design and optimization, along a coordinated push for novel applications. EuPRAXIADN is a new MSCA Doctoral Network for a cohort of 10 Fellows between universities, research centers and industry that will carry out an interdisciplinary and cross-sector plasma accelerator research and training program for this new research infrastructure. The network focuses on scientific and technical innovations and on boosting the career prospects of its Fellows.

Eupraxia是第一个基于新的血浆加速概念和激光技术开发专用粒子加速器研究基础架构的欧洲项目。它着重于电子加速器和基础技术，其用户社区的开发以及欧洲现有的加速器基础设施的开发。它在2021年6月作为欧洲优先事项的ESFRI路线图中被接受了具有战略上重要的研究基础设施的。为了充分利用这种突破性设施的潜力，在血浆和激光研发中迫切需要进步，研究设施设计和优化，并沿着对新应用的协调推动。 EupraxiADN是一个新的MSCA博士网络，可在大学，研究中心和行业之间组成10个研究员，该公司将在这项新的研究基础设施中执行跨学科和跨部门等离子体加速器研究和培训计划。该网络着重于科学和技术创新，并促进其研究员的职业前景。